Departamento de Microbiologia Geral, Instituto de Microbiologia Prof. Paulo de Góes, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Mem Inst Oswaldo Cruz. 2011 Jun;106(4):507-9. doi: 10.1590/s0074-02762011000400021.
In the current study, we evaluated the mechanism of action of miltefosine, which is the first effective and safe oral treatment for visceral leishmaniasis, in Leishmania amazonensis promastigotes. Miltefosine induced a process of programmed cell death, which was determined by the externalization of phosphatidylserine, the incorporation of propidium iodide, cell-cycle arrest at the sub-G0/G1 phase and DNA fragmentation into oligonucleosome-sized fragments. Despite the intrinsic variation that is detected in Leishmania spp, our results indicate that miltefosine causes apoptosis-like death in L. amazonensis promastigote cells using a similar process that is observed in Leishmania donovani.
在本研究中,我们评估了米替福新的作用机制,米替福新是治疗内脏利什曼病的第一种有效且安全的口服药物。米替福新诱导了程序性细胞死亡过程,这是通过磷脂酰丝氨酸的外化、碘化丙啶的掺入、细胞周期在亚 G0/G1 期停滞以及 DNA 片段化为寡核苷酸大小的片段来确定的。尽管在利什曼原虫中检测到内在变异,但我们的结果表明,米替福新使用类似于在利什曼原虫中观察到的过程,导致 L. amazonensis 前鞭毛体细胞发生类似凋亡的死亡。